Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter
Active & Responsive

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

for
Sickle Cell Disease
Location: New York NY, Columbus OH, St Louis MO, Los Angeles CA,
Sponsor: Kamau Therapeutics

Sex: All

Age: 12 - 50

Code: NCT04819841

Phase 1, Phase 2, Recruiting
Active & Responsive

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease

for
Sickle Cell Disease
Location: Los Angeles CA, Davis CA, Oakland CA
Sponsor: Mark Walters, MD

Sex: All

Age: 12 - 35

Code: NCT04774536

Phase 1, Phase 2, Recruiting
Active & Responsive

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

for
Acute Myeloid Leukemia, Chronic Myeloid Leukemia,
Location: Columbus OH, Westwood KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18 - 65

Code: NCT03533816

Phase 1, Recruiting
Active & Responsive

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Pittsburgh PA, St Louis MO, Seattle WA
Sponsor: Sawa Ito, MD

Sex: All

Age: 18+

Code: NCT06529731

Phase 2, Recruiting
Active & Responsive

Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium

for
Asherman Syndrome, Atrophic Endometrium,
Location: Orange CT
Sponsor: Hugh Taylor

Sex: Female

Age: 18 - 40

Code: NCT05343572

Early Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

for
Graft Vs Host Disease
Location: Lake Success NY
Sponsor: Northwell Health

Sex: All

Age: 18+

Code: NCT06681922

Phase 1, Phase 2, Recruiting
Active & Responsive

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

for
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,
Location: Boston MA, Atlanta GA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT07020533

Phase 1, Recruiting
Active & Responsive

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

for
Pediatric Tumor of CNS, Pediatric Tumor of Brain,
Location: Orange CA
Sponsor: Neonc Technologies, Inc.

Sex: All

Age: 5 - 18

Code: NCT06357377

Phase 1, Recruiting
Active & Responsive

Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies

for
Congenital Fibrosis of Extraocular Muscles,
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 0+

Code: NCT03059420

Recruiting
New

Peer Support Intervention for Caregivers of Patients Undergoing HSCT

for
Hematopoietic Stem Cell Transplantation
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT07577674

Recruiting

Donor-Derived Viral Specific T-cells (VSTs)

for
Allogeneic Stem Cell Transplant, Viral Infection,
Location: Akron OH, Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT02048332

Phase 1, Phase 2, Recruiting

MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome

for
Trauma, Adult Stem Cells
Location: Houston TX
Sponsor: Healios K.K.

Sex: All

Age: 18+

Code: NCT04533464

Phase 2, Recruiting

T Cell Therapy of Opportunistic Cytomegalovirus Infection

for
Cytomegalovirus Infections, Hematopoietic Stem Cell Transplant,
Location: Cleveland OH
Sponsor: Mari Dallas

Sex: All

Age: 0+

Code: NCT02982902

Early Phase 1, Recruiting

Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation

for
Allogeneic Hematopoietic Stem Cell Transplantation
Location: Cleveland OH
Sponsor: Mari Dallas

Sex: All

Age: 0+

Code: NCT03378102

Early Phase 1, Recruiting

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

for
Leukemia, Hematopoetic Stem Cell Transplantation,
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 21 - 55

Code: NCT06643221

Early Phase 1, Recruiting

Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

for
Hematopoietic Stem Cell Transplant
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT05945121

Recruiting

Massage Impact on Sleep in Pediatric Oncology

for
Cancer, Pediatric Cancer, Chemotherapy Effect,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 12 - 21

Code: NCT06892158

Recruiting

Nutrition OUtReach In Systems of Healthcare

for
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION,
Location: Fairway KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 8 - 70+

Code: NCT06802406

Recruiting

Shingrix In Recipients of Allogeneic Transplants

for
Bone Marrow Transplant, Stem Cell Transplant
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT05775718

Phase 2, Recruiting

Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients

for
Stem Cell Transplant Complications, Sleep Disturbance
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 9 - 17

Code: NCT06468618

Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial